First Time Loading...

Exagen Inc
NASDAQ:XGN

Watchlist Manager
Exagen Inc Logo
Exagen Inc
NASDAQ:XGN
Watchlist
Price: 1.85 USD -3.14%
Updated: May 16, 2024

Exagen Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Exagen Inc
Gross Profit Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Exagen Inc
NASDAQ:XGN
Gross Profit
$29.5m
CAGR 3-Years
5%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Gross Profit
$36.1B
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
10%
Gilead Sciences Inc
NASDAQ:GILD
Gross Profit
$20.8B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Gross Profit
$19.6B
CAGR 3-Years
1%
CAGR 5-Years
0%
CAGR 10-Years
3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Gross Profit
$8.6B
CAGR 3-Years
16%
CAGR 5-Years
27%
CAGR 10-Years
23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Gross Profit
$11.3B
CAGR 3-Years
12%
CAGR 5-Years
13%
CAGR 10-Years
18%

See Also

What is Exagen Inc's Gross Profit?
Gross Profit
29.5m USD

Based on the financial report for Dec 31, 2023, Exagen Inc's Gross Profit amounts to 29.5m USD.

What is Exagen Inc's Gross Profit growth rate?
Gross Profit CAGR 5Y
12%

Over the last year, the Gross Profit growth was 38%. The average annual Gross Profit growth rates for Exagen Inc have been 5% over the past three years , 12% over the past five years .